TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution

Brand(s)

Last updated

2026-02-09

Summary

Product

TARO-CANDESARTAN

Issue

Health products - Product quality

What to do

Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

Distribution

National

Brand	Product Name	Market Authorization	Dosage Form	Strength	Lot numbers
TARO	TARO-CANDESARTAN	DIN 02380684	Tablet	CANDESARTAN CILEXETIL 4 MG	PTG4320A PTG4321A
TARO	TARO-CANDESARTAN	DIN 02380692	Tablet	CANDESARTAN CILEXETIL 8 MG	PTF3333A PTF3338A PTF5487A PTF5488A PTF5489A PTF5490A PTF5491A PTF6159A PTG1103A PTG1083A
TARO	TARO- CANDESARTAN	DIN 02380706	Tablet	CANDESARTAN CILEXETIL 16 MG	PTF3339A PTF5498A PTF5497A PTG1386A PTG1387A PTG1388A
RAN	RAN-CANDESARTAN	DIN 02380714	Tablet	CANDESARTAN CILEXETIL 32 MG	PTF3279A PTF3280A PTF3281A PTF3282A PTF3283A

Affected lots were manufactured using an active ingredient that was out of specification for dissolution.

Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.

Background

Depth of recall: Retailers, Wholesalers, Pharmacies

Details

Original published date: 2026-02-09

Alert / recall type

Health product recall

Receive emails about new and updated recall and safety alerts.